Single staff cystectomy in a low-volume center: Oncological outcomes and complications.
Journal
Canadian Urological Association journal = Journal de l'Association des urologues du Canada
ISSN: 1911-6470
Titre abrégé: Can Urol Assoc J
Pays: Canada
ID NLM: 101312644
Informations de publication
Date de publication:
Nov 2021
Nov 2021
Historique:
pubmed:
18
5
2021
medline:
18
5
2021
entrez:
17
5
2021
Statut:
ppublish
Résumé
Radical cystectomy (RC) with bilateral pelvic lymph node dissection (PLND) is a complex surgical procedure, associated with substantial perioperative complications. Previous studies suggested reserving it to high-volume centers in order to improve oncological and perioperative outcomes. However, only limited data exist regarding low-volume centers with highly experienced surgeons. We aimed to assess oncological and perioperative outcomes after RC performed by experienced surgeons in the low-volume center of Luzerner Kantonsspital, Lucerne, CH. We retrospectively analyzed the data of 158 patients who underwent RC and PLND performed between 2009 and 2019 at a single low-volume center by three experienced surgeons, each having performed at least 50 RCs. Complications were graded according to the 2004 modified Clavien-Dindo grading system. A total of 110 patients (70%) received an incontinent urinary diversion (ileal conduit or ureterocutaneostomy) and 48 patients (30%) received a continent urinary diversion (ileal orthotopic neobladder, ureterosigmoidostomy, or Mitrofanoff pouch). Median operating time was 419 minutes (interquartile range [IQR] 346-461). Overall, at RC specimen, 71.5% of patients had urothelial carcinoma, 12.6% squamous, 3.1% sarcomatoid, 1.2% glandular, and 0.6% small cell carcinoma. Median number of lymph nodes removed was 23 (IQR 16-29.5). Positive margins were found in eight patients (5.1%). Overall five-year survival rate was 52.4%. The complication rate was 56.3%: 143 complications were found in 89 patients, 36 (22.8%) with Clavien ≥3. The 30-day mortality rate was 2.5%. RC could be safely performed in a low-volume center by experienced surgeons with comparable outcomes to high-volume centers.
Identifiants
pubmed: 33999810
pii: cuaj.7171
doi: 10.5489/cuaj.7171
pmc: PMC8641899
doi:
Types de publication
Journal Article
Langues
eng
Pagination
E582-E587Références
J Urol. 2014 Mar;191(3):681-7
pubmed: 24099746
Investig Clin Urol. 2017 May;58(3):171-178
pubmed: 28480342
Nat Rev Urol. 2018 Nov;15(11):686-692
pubmed: 30104615
Eur Urol. 2020 Nov;78(5):719-730
pubmed: 32624275
Postgrad Med J. 2007 Aug;83(982):556-60
pubmed: 17675551
Eur Urol. 2016 Jul;70(1):93-105
pubmed: 26935559
Urology. 2018 Apr;114:87-94
pubmed: 29305205
J Urol. 2007 Dec;178(6):2308-12; discussion 2313
pubmed: 17936804
BJU Int. 2014 Jul;114(1):46-55
pubmed: 24219110
Eur Urol. 2017 Mar;71(3):462-475
pubmed: 27375033
BJU Int. 2017 May;119 Suppl 5:26-32
pubmed: 28544301
BJU Int. 2011 Oct;108(8 Pt 2):E258-65
pubmed: 21314812
J Urol. 2013 Feb;189(2):474-9
pubmed: 23017529
J Urol. 2010 Jun;183(6):2165-70
pubmed: 20399473
J Urol. 2010 Feb;183(2):510-4
pubmed: 20006884
J Urol. 2010 Jul;184(1):87-91
pubmed: 20478596
BJU Int. 2017 Aug;120(2):239-245
pubmed: 28192632
J Urol. 2016 May;195(5):1368-1376
pubmed: 26551296
Eur Urol. 2011 May;59(5):775-83
pubmed: 21310525
World J Urol. 2009 Feb;27(1):33-8
pubmed: 19020884
Eur Urol. 2020 Feb;77(2):223-250
pubmed: 31753752
Urol Oncol. 2007 Jan-Feb;25(1):66-71
pubmed: 17208142
Eur Urol. 2015 Mar;67(3):363-75
pubmed: 25582930
Ann Surg. 2004 Aug;240(2):205-13
pubmed: 15273542
Eur Urol Focus. 2016 Apr;2(1):19-29
pubmed: 28723446
Bladder Cancer. 2016 Jul 27;2(3):319-327
pubmed: 27500199
Ann Oncol. 2019 Nov 1;30(11):1697-1727
pubmed: 31740927
Urol Oncol. 2013 Nov;31(8):1663-9
pubmed: 22687566
Patient Prefer Adherence. 2016 Oct 28;10:2181-2187
pubmed: 27822019
BJU Int. 2019 May 4;:
pubmed: 31055865
Eur Urol Focus. 2020 Sep 15;6(5):975-981
pubmed: 30772360